This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Universitá Degli Studi Di Torino, Other. Active years: 2011-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 16 
2 out of 834,513 Years Active: 2011-2020
Title: Elena Quaglino: Advancing Therapeutic Innovations from Turin
Introduction
Elena Quaglino, an innovative inventor based in Turin, Italy, has made significant contributions to the field of biotechnology with her pioneering research and patents. With a portfolio comprising three patents, her work primarily focuses on therapeutic applications related to cancer immunology and molecular biology.
Latest Patents
Among her most recent patents is a groundbreaking invention involving nucleic acid molecules that encode for chimeric chondroitin sulfate proteoglycan 4 (CSPG4) proteins. This invention outlines a novel approach where the chimeric CSPG4 protein is structured to combine portions derived from both human and canine CSPG4 sequences. This innovative molecular design could lead to significant advancements in therapeutic strategies. Another notable invention pertains to DNA plasmids containing sequences that code for various fragments of the 185 oncoprotein. These oncoproteins have shown potential in inducing an immune response against tumors that overexpress p185, indicating promising possibilities for future cancer therapies.
Career Highlights
Elena has collaborated with prestigious institutions, including the Università Degli Studi di Torino, where she continues to engage in groundbreaking research. Her patents reflect her commitment to addressing critical health challenges through innovative solutions in biotechnology.
Collaborations
Throughout her career, Elena Quaglino has worked alongside prominent colleagues, including Federica Cavallo and Augusto Amici. Their collaborative efforts have fostered a rich environment for innovation, enabling significant advancements in their respective fields.
Conclusion
Elena Quaglino stands out as a remarkable inventor in the biotechnology sector. Her contributions through innovative patents and collaborative research underline her dedication to developing therapeutic solutions that can significantly improve health outcomes. As her work continues to evolve, she remains a key figure in shaping the future of cancer immunotherapy and molecular innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile